{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "339",
                "352"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "Nie stosowano"
        },
        {
            "identifier": "T2",
            "position": [
                "353",
                "379"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "leczenia farmakologicznego"
        },
        {
            "identifier": "T3",
            "position": [
                "516",
                "542"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zaburzeniami przewodnictwa"
        },
        {
            "identifier": "T4",
            "position": [
                "619",
                "634"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan do\u015b\u0107 dobry"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 8 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nNie stosowano leczenia farmakologicznego.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opiec z zaburzeniami przewodnictwa przyj\u0119ty do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:5.27[10\\\\^3/ul]\n    RBC:4.03[10\\\\^6/ul]\n    HGB:12.0[g/dl]\n    HCT:33.3[%]\n    MCV:82.6[fl]\n    MCH:29.8[pg]\n    MCHC:36.0[g/dl]\n    PLT:257.0[10\\\\^3/ul]\n    RDW-SD:37.6[fl]\n    RDW-CV:12.4[%]\n    PDW:10.7[fl]\n    MPV:9.6[fl]\n    P-LCR:20.8[%]\n    PCT:0.3[%]\n    NEUTR#:2.21[10\\\\^3/ul]\n    NEUTR%:41.9[%]\n    LYMPH#:2.42[10\\\\^3/ul]\n    LYMPH%:45.9[%]\n    MONO#:0.50[10\\\\^3/ul]\n    MONO%:9.50[%]\n    EO#:0.12[10\\\\^3/ul]\n    EO%:2.30[%]\n    BASO#:0.02[10\\\\^3/ul]\n    BASO%:0.40[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nKwas mlekowy: LAC:13.30[mg/dl]\nKwas mlekowy: LAC:45.50[mg/dl]\nTSH: TSH:1.57[uIU/ml]\nFT3 III: FT3 III:4.10[pg/ml]\nFT4II: FT4II:1.39[ng/dl]\n------------------------------------------------\nICD10\n------------------------------------------------\nI45.6\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\nO69\n89.43\nL69\n------------------------------------------------"
}